Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error instead of the clinical-trial study record, with no visible content or layout changes.
    Difference
    0.2%
    Check dated 2026-10-03T21:41:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    403 Forbidden content is removed, and the page now displays the study record instead of an error. This enables access to the NCT03665545 details.
    Difference
    0.5%
    Check dated 2026-09-26T21:38:29.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with a minimal HTML scaffold, indicating restricted access to the study record. This replaces the previously visible study content, signaling an access restriction rather than study details.
    Difference
    19%
    Check dated 2026-09-19T21:01:27.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a minor internal update without changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T21:51:46.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page's content or formatting. No core study information, eligibility criteria, or results appear to be affected.
    Difference
    0.1%
    Check dated 2026-08-08T16:47:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.